Acute hematogenous osteomyelitis, left ankle and foot
ICD-10 M86.072 is a billable code used to indicate a diagnosis of acute hematogenous osteomyelitis, left ankle and foot.
Acute hematogenous osteomyelitis is a severe bone infection that occurs when bacteria enter the bloodstream and infect the bone tissue. In the case of M86.072, the infection specifically affects the left ankle and foot. This condition is characterized by sudden onset of pain, swelling, and tenderness in the affected area, often accompanied by fever and malaise. The infection can lead to bone necrosis if not treated promptly, as the bacteria can cause inflammation and disrupt blood flow to the bone. Diagnosis typically involves imaging studies such as X-rays or MRI, along with laboratory tests to identify the causative organism. Treatment usually includes antibiotics and may require surgical intervention to remove necrotic tissue. Early recognition and management are crucial to prevent complications such as chronic osteomyelitis or limb loss.
Detailed clinical notes including symptoms, imaging results, and treatment plans.
Patients presenting with sudden onset of pain and swelling in the ankle or foot, often following a recent infection or injury.
Orthopedic surgeons must document the extent of bone involvement and any surgical interventions performed.
Laboratory results identifying the pathogen, treatment regimens, and response to therapy.
Patients with systemic symptoms of infection and localized bone pain, requiring antibiotic management.
Infectious disease specialists should document the rationale for antibiotic choice and duration of treatment.
Used when joint aspiration is performed to relieve pressure or obtain fluid for analysis.
Document the indication for the procedure and the findings from the aspiration.
Orthopedic specialists should note any findings that may indicate infection.
Common causes include bacterial infections, particularly Staphylococcus aureus, and conditions that predispose individuals to infections, such as diabetes or immunocompromised states.
